Publikációk

Összesen 117 tudományos publikáció 2021-ben, ∑=IF 720.392
50 publikáció, ahol a projekt résztvevője első szerző, ∑IF=136,924
65 publikáció, ahol a projekt résztvevője levelező szerző, ∑IF=201,203
47 publikáció, ahol a projekt résztvevője első és levelező szerző, ∑IF=132,198
20 publikáció 10 es IF feletti folyóiratban, ∑IF=413,543

Összesen 118 tudományos publikáció 2022-ben, ∑IF=673,806
28 publikáció, ahol a projekt résztvevője első szerző, ∑IF=82,765
45 publikáció, ahol a projekt résztvevője levelező szerző, ∑IF=153,189
16 publikáció, ahol a projekt résztvevője első és levelező szerző, ∑IF=61,313
11 publikáció, 10-es IF feletti folyóiratban, ∑IF=309,741

Összesen 138 tudományos publikáció 2023-ban, ∑IF=1278,9
33 publikáció, ahol a projekt résztvevője első szerző, ∑IF=224,2
40 publikáció, ahol a projekt résztvevője levelező szerző, ∑IF=204,7
28 publikáció, ahol a projekt résztvevője első és levelező szerző, ∑IF=158,5
23 publikáció, 10-es IF feletti folyóiratban, ∑IF=914,5

IF>10 publikációk 2021-ben:

1. André, E. M. Circuelos, D. Juric, S. Loibl, M. Campone, I. A. Mayer, G. Rubovszky, T. Yamashita, B. Kauffman, Y.-S. Lu, K. Inoue, Z. Pápai, M. Takahashi, F. Ghaznawi, D. Mills, M. Kaper, M. Miller, P. F. Conte, H. Iwata, H. S. Rugo

Alpelisib Plus Fulvestrant for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer : Final Overall Survival Results From SOLAR-1.

ANNALS OF ONCOLOGY 2021 Febr;32(2):208-217

IF: 51,769

2. Zsuzsanna Antal, Attila Kalman, Peter Voros, Bahrehmand Kiarash, Timea Echim, Tamás Mersich, Zoltan Novak, Tamás Sztipits, Dániel Wettstein et al.

Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study.

ANAESTHESIA 2021 Jun;76(6):748-758.

IF: 12,893

3. Paolo A. Ascierto, Brigitte Dréno, James Larkin, Antoni Ribas, Gabriella Liszkay, Michele Maio, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas, Luis de la Cruz-Merino, Victoria Atkinson, Caroline Dutriaux, Claus Garbe, Jessie Hsu, Surai Jones, Haocheng Li, Edward McKenna, Athina Voulgari, Grant A. McArthur

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF V600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study.

CLINICAL CANCER RESEARCH 2021 Oct;27(19):5225-5235.

IF: 13,801

4. Alberto Benazzo, Stefan Schwarz, Florian Frommlet, Katharina Sinn, Thomas Schweiger, Thomas Klikovits, Alireza Mir Hoda, Bernhard Moser, Jose Ramon Matilla, Ferenc Renyi Vamos, György Lang, Peter Jaksch, Matteo Di Nardo, Lorenzo Del Sorbo, Shahrokh Taghavi, Shaf Keshavjee, Walter Klepetko, Marcelo Cypel, Konrad Hoetzenecker

Donor ventilation parameters as predictors for length of mechanical ventilation after lung transplantation : Results of a prospective multicenter study.

JOURNAL OF HEART AND LUNG TRANSPLANTATION 2021 Jan;40(1):33-41.

IF: 13,569

5. Qing Cheng, Antonella Roveri, Giorgio Cozza, Luciana Bordin, Isabelle Rohn, Tanja Schwerdtle, Anna Kipp, Fulvio Ursini, Matilde Maiorino, Giovanni Miotto, Elias S. J. Arnér

Production and purification of homogenous recombinant human selenoproteins reveals a unique codon skipping event in E. coli and GPX4-specific affinity to bromosulfophthalein.

REDOX BIOLOGY 2021 Oct;46:102070.

IF: 10,707

6. Cibula, L. Dostalek, P. Hillemanns, G. Scambia, J. Jarkovsky, J. Persson, F. Raspagliesi, Z. Novak, A. Jaeger, M. E. Capilna, V. Weinberger, J. Klat, R. L. Schmidt, A. Lopez, G. Scibilia, R. Pareja, A. Kucukmetin, L. Kreitner, A. El-Balat, G. J. R. Pereira, S. Laufhütte, D. Isla-Ortiz, T. Toptas, B. Gil-Ibanez, I. Vergote, I. Runnenbaum

Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement : ABRAX international retrospective cohort study.

EUROPEAN JOURNAL OF CANCER 2021 Jan;143:88-110.

IF: 10,002

7. Éva Dóka, Elias S. J. Arnér, Edward E Schmidt, Tobias P. Dick, Albert van der Vliet, Jing Yang, Réka Szatmári, Tamás Ditrói, John L. Wallace, Giuseppe Cirino, Kenneth Olson, Hozumi Motohashi, Jon M. Fukuto, Michael D. Pluth, Martin Feelisch, Takaaki Akaike, David A. Wink, Louis J. Ignarro, Péter Nagy

Comment on “Evidence that the ProPerDP method is inadequate for protein persulfidation detection due to lack of specificity”.

SCIENCE ADVANCES 2021 Apr;7(17):eabe7006.

IF: 14,957

8. Katalin Erdélyi, Tamás Ditrói, Henrik J. Johansson, Ágnes Czikora, Noémi Balog, Laxmi Silwal-Pandit, Tomoaki Ida, Judit Olasz, Dorottya Hajdú, Zoltán Mátrai, Orsolya Csuka, Koji Uchida, József Tóvári, Olav Engebraten, Takaaki Akaike, Anne-Lise Børresen Dale, Miklós Kásler, Janne Lethiö, Péter Nagy

Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation.

       PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2021 Nov;118(45):e2100050118 (2021)
IF: 12,779

9. Jan G. Felber, Lukas Zeisel, Lena Poczka, Karoline Scholzen, Sander Busker, Martin S. Maier, Ulrike Theisen, Christina Brandstädter, Katja Becker, Elias S. J. Arnér, Julia Thorn-Seshold, Oliver Thorn-Seshold

Selective, Modular Probes for Thioredoxins Enabled by Rational Tuning of a Unique Disulfide Structure Motif.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 2021 Jun;143(23):8791-8803.
IF: 16,383

10. Helen Gogas, Reinhard Dummer, Paolo A. Ascierto, Ana Arance, Mario Mandalà, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsová, Ralf Gutzmer, Vanna Chiarion Sileni, Caroline Dutriaux, Naoya Yamazaki, Carmen Loquai, Paola Queirolo, Groot J. de Willem, Abir T. Sellier, Jeanne Suissa, Juliette Murris, Ashwin Gollerkeri, Caroline Robert, Keith T. Flaherty

Corrigendum to ‘Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib : Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)’ [European Journal of Cancer 152 (2021) 116-128].
EUROPEAN JOURNAL OF CANCER 2022 Jan;160:287-288.
IF: 10,002

11. Helen Gogas, Reinhard Dummer, Paolo A. Ascierto, Ana Arance, Mario Mandalà, Gabriella Liszkay, Claus Garbe, Dirk Schadendorf, Ivana Krajsová, Ralf Gutzmer, Vanna Chiarion Sileni, Caroline Dutriaux, Naoya Yamazaki, Carmen Loquai, Paola Queirolo, Groot Jan de Willem, Abir Tadmouri Sellier, Jeanne Suissa, Juliette Murris, Ashwin Gollerkeri, Caroline Robert, Keith T. Flaherty

Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib : Results from a multicentre, open-label, randomised, phase III study (COLUMBUS).

EUROPEAN JOURNAL OF CANCER 2021 Jul;152:116-128.
IF: 10,002

12. Jean-Michel Hannoun-Levi, Cristina Gutierrez, Csaba Polgar, Vratislav Strnad, BCWG of the GEC-ESTRO
    Letter comments on : The impact of isolated local recurrence on long-term outcome in early-breast cancer patients after breast-conserving therapy.
    EUROPEAN JOURNAL OF CANCER 2021 Dec;159:224-226.
    IF: 10,002

13. Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri, Robert I. Haddad, Makoto Tahara, Jean Bourhis, Kevin Harrington, Peter Mu-Hsin Chang, Jin-Ching Lin, Mohammad Abdul Razaq, Maria Margarida Teixeira, József Lövey, Jerome Chamois, Antonio Rueda, Chaosu Hu, Lara A. Dunn, Mikhail Vladimirovich Dvorkin, Steven De Beukelaer, Dmitri Pavlov, Holger Thurm, Ezra Cohen
    Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
    LANCET ONCOLOGY 2021 Apr;22(4):450-462.
    IF: 54,433

14. Erica L. Mayer, Amylou C. Dueck, Miguel Martin, Gabor Rubovszky, Harold J. Burstein, Meritxell Bellet-Ezquerra, Kathy D. Miller, Nicholas Zdenkowski, Eric P. Winer, Georg Pfeiler, Matthew Goetz, Manuel Ruiz-Borrego, Daniel Anderson, Zbigniew Nowecki, Sibylle Loibl, Stacy Moulder, Alistair Ring, Florian Fitzal, Tiffany Traina, Arlene Chan, Hope S. Rugo, Julie Lemieux, Fernando Henao, Alan Lyss, Silvia Antolin Novoa, Antonio C. Wolff, Marcus Vetter, Daniel Egle, Patrick G. Morris, Eleftherios P. Mamounas, Miguel J. Gil-Gil, Aleix Prat, Hannes Fohler, Otto Metzger Filho, Magdalena Schwarz, Carter DuFrane, Debora Fumagalli, Kathy Puyana Theall, Dongrui Ray Lu, Cynthia Huang Bartlett, Maria Koehler, Christian Fesl, Angela DeMichele, Michael Gnant

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS) : interim analysis of a multicentre, open-label, randomised, phase 3 study.

LANCET ONCOLOGY 2021 Feb;22(2):212-222.
IF: 54,433

15. Anna-Theresa Mellis, Albert L. Misko, Sita Arjune, Ye Liang, Katalin Erdélyi, Tamás Ditrói, Alexander T. Kaczmarek, Peter Nagy, Guenter Schwarz
    The role of glutamate oxaloacetate transaminases in sulfite biosynthesis and H₂S metabolism.
    REDOX BIOLOGY 2021 Jan;38:101800.
    IF: 10,707

16. Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Y.-S. Cheng, Yves Fradet, Stephane Oudard, Christof Vulsteke, Rafael Morales Barrera, Aude Fléchon, Seyda Gunduz, Yohann Loriot, Alejo Rodriguez-Vida, Ronac Mamtani, Evan Y. Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, KEYNOTE-361 Investigators

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361) : a randomised, open-label, phase 3 trial.

LANCET ONCOLOGY 2021 Jul;22(7):931-945.

IF: 54,433

17. Pierre Sabatier, Christian M. Beusch, Radosveta Gencheva, Qing Cheng, Roman Zubarev, Elias S. J. Arnér

Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin.

REDOX BIOLOGY 2021 Nov;48:102184.

IF: 10,707

18. Stefan Schwarz, Alberto Benazzo, Daniela Dunkler, Moritz Muckenhuber, Lorenzo Del Sorbo, Matteo Di Nardo, Katharina Sinn, Bernhard Moser, José Ramon Matilla, Gyoergy Lang, Shahrokh Taghavi, Ferenc Renyi Vamos, Peter Jaksch, Marcelo Cypel, Shaf Keshavjee, Walter Klepetko, Konrad Hoetzenecker

Ventilation parameters and early graft function in double lung transplantation.

JOURNAL OF HEART AND LUNG TRANSPLANTATION 2021 Jan;40(1):4-11.

IF: 13,569

19. Lumin Yang, Yafei Zhang, Ke Zhang, Zhongping Liu, Tengfei He, Xiaowei Zheng, Lei Li, Elias S. J. Arnér, Zhenhua Zhang, Jinsong Zhang

Evaluation of dithiothreitol-oxidizing capacity (DOC) as a serum biomarker for chronic hepatitis B in patients exhibiting normal alanine aminotransferase levels : a pilot study towards better monitoring of disease.

ECLINICALMEDICINE 2021 Oct;42:101180.

IF: 17,033

20. Zsuzsanna Antal, Attila Kalman, Peter Voros, Bahrehmand Kiarash, Timea Echim, Tamás Mersich, Zoltan Novak, Tamás Sztipits, Dániel Wettstein et al.

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.

BRITISH JOURNAL OF SURGERY 2021 Sep;108(9):1056-1063.

IF: 11,122

IF>10 publikációk 2022-ben:

1. Ágnes Czikora, Katalin Erdélyi, Tamás Ditrói, Noémi Szántó, Eszter Petra Jurányi, Szilárd Szanyi, József Tóvári, Tamás Strausz, Péter Nagy

Cystathionine β-synthase overexpression drives metastatic dissemination in pancreatic ductal adenocarcinoma via inducing epithelial-to-mesenchymal transformation of cancer cells.

REDOX BIOLOGY 2022 Nov;57:102505.

IF:10,787

2. Reinhard Dummer, Paola Queirolo, Pauline Gerard Duhard, Youyou Hu, Dao Wang, Sergio Jobim de Azevedo, Caroline Robert, Paolo Antonio Ascierto, Vanna Chiarion-Sileni, Paolo Pronzato, Francesco Spagnolo, Karmele Mujika Eizmendi, Gabriella Liszkay, Luis de la Cruz Merino, Hussein Tawbi

Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.

LANCET ONCOLOGY 2022 Sep;23(9):1145-1155.

IF: 54,433

3. Reinhard Dummer, Keith T. Flaherty, Caroline Robert, Ana Arance, Jan Willem B. de Groot, Claus Garbe, Helen J. Gogas, Ralf Gutzmer, Ivana Krajsová, Gabriella Liszkay, Carmen Loquai, Mario Mandalà, Dirk Schadendorf, Naoya Yamazaki, Alessandra di Pietro, Jean Cantey-Kiser, Michelle Edwards, Paolo A. Ascierto

COLUMBUS 5-Year Update : A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma.

JOURNAL OF CLINICAL ONCOLOGY 2022 Dec;40(36):4178-4188.

IF: 50,717

4. Fata Francesca Fata, Radosveta Gencheva, Qing Cheng, Rachel Lullo, Matteo Ardini, Ilaria Silvestri, Federica Gabriele, Rodolfo Ippoliti, Christina A. Bulman, Judy A. Sakanari, David L. Williams, Elias S. J. Arnér, Francesco Angelucci

Biochemical and structural characterizations of thioredoxin reductase selenoproteins of the parasitic filarial nematodes Brugia malayi and Onchocerca volvulus.

REDOX BIOLOGY 2022 May;51:102278.

IF:10,787

5. Tamás Gáll, Péter Nagy, Dorottya Garai, László Potor, György Jázon Balla, György Balla, József Balla

Overview on hydrogen sulfide-mediated suppression of vascular calcification and hemoglobin/heme-mediated vascular damage in atherosclerosis.

REDOX BIOLOGY 2022 Nov;57:102504

IF: 10,787

6. Radosveta Gencheva, Elias S. J. Arnér

Thioredoxin Reductase Inhibition for Cancer Therapy.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 2022 Jan;62:177-196.

IF: 16,459

7. Michael Gnant, Amylou C. Dueck, Sophie Frantal, Miguel Martin, Hal J. Burstein, Richard Greil, Peter Fox, Antonio C. Wolff, Arlene Chan, Eric P. Winer, Georg Pfeiler, Kathy D. Miller, Marco Colleoni, Jennifer M. Suga, Gabor Rubovsky, Judith M. Bliss, Ingrid A. Mayer, Christian F. Singer, Zbigniew Nowecki, Olwen Hahn, Jacqui Thomson, Norman Wolmark, Kepa Amillano, Hope S. Rugo, Guenther G. Steger, Blanca Hernando Fernández de Aránguiz, Tufia C. Haddad, Antonia Perelló, Meritxell Bellet, Hannes Fohler, Otto Metzger Filho, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, Kathy P. Theall, Dongrui R. Lu, Kathleen Tenner, Christian Fesl, Angela DeMichele, Erica L. Mayer, PALLAS groups and investigators

Adjuvant Palbociclib for Early Breast Cancer : The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).

JOURNAL OF CLINICAL ONCOLOGY 2022 Jan;40(3):282-293.

IF: 50,717

8. Viktor Kožich, Bernd C. Schwahn, Jitka Sokolová, Michaela Křížková, Tamas Ditroi, Jakub Krijt, Youssef Khalil, Tomáš Křížek, Tereza Vaculíková-Fantlová, Blanka Stibůrková, Philippa Mills, Peter Clayton, Kristýna Barvíková, Holger Blessing, Jolanta Sykut-Cegielska, Carlo Dionisi-Vici, Serena Gasperini, Ángeles García-Cazorla, Tobias B. Haack, Tomáš Honzík, Pavel Ješina, Alice Kuster, Lucia Laugwitz, Diego Martinelli, Francesco Porta, René Santer, Guenter Schwarz, Peter Nagy

Human ultrarare genetic disorders of sulfur metabolism demonstrate redundancies in H₂S homeostasis.

REDOX BIOLOGY 2022 Dec;58:102517.

IF: 10,787

9. Stefanie Renken, Takahiro Nakajima, Isabelle Magalhaes, Jonas Mattsson, Andreas Lundqvist, Elias S. J. Arnér, Rolf Kiessling, Stina Linnea Wickström

Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress.

JOURNAL FOR IMMUNOTHERAPY OF CANCER 2022 Jun;10(6):e004458.

IF: 12,469

10. Eric Solary, Patricia Blanc, Michael Boutros, Charis Girvalaki, Franco Locatelli, Rene H. Medema, Péter Nagy, Josep Tabernero

UNCAN.eu, a European initiative to UNderstand CANcer.

CANCER DISCOVERY 2022 Nov;12(11):2504-2508.

IF: 38,272

11. Lukas Zeisel, Jan G. Felber, Karoline C. Scholzen, Lena Poczka, Dorian Cheff, Martin S. Maier, Qing Cheng, Min Shen, Matthew D. Hall, Elias S. J. Arnér, Julia Thorn-Seshold, Oliver Thorn-Seshold

Selective cellular probes for mammalian thioredoxin reductase TrxR1: Rational design of RX1, a modular 1,2-thiaselenane redox probe.

CHEM 2022 May;8(5):1493-1517.

IF: 25,832

IF>10 publikációk 2023-ban:

1. Andrea Domán, Éva Dóka, Dorottya Garai, Virág Bogdándi, György Balla, József Balla, Péter Nagy

Interactions of reactive sulfur species with metalloproteins.

REDOX BIOLOGY 2023 Apr;60:102617.

IF: 11,4

2. Péter Nagy

Recent advances in sulfur biology and chemistry.

REDOX BIOLOGY 2023 Jul;63:102716.

IF: 11,4

3. Gábor Rubovszky, László Torday

Comment on ‘therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study’ by dr steffie l. Groenland et al.

ANNALS OF ONCOLOGY 2023 Jul;34(7):628-629.

IF: 50,5

4. Attila Andor, Mahendravarman Mohanraj, Zsuzsanna Anna Pató, Katalin Úri, Beáta Biri-Kovács, Qing Cheng, Elias S. J. Arnér

Txnl1 has dual functions as a redox active thioredoxin-like protein as well as an atp- and redox-independent chaperone.

REDOX BIOLOGY 2023 Nov:67:102897

IF: 11,4

5. Dorian M. Cheff, Chuying Huang, Karoline C. Scholzen, Radosveta Gencheva, Michael H. Ronzetti, Qing Cheng, Matthew D. Hall, Elias S. J. Arnér

The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1..

REDOX BIOLOGY 2023 Jun:62:102703

IF: 11,4

6. András Wéber, Mathieu Laversanne, Péter Nagy, István Kenessey, Isabelle Soerjomataram, Freddie Bray

Gains in life expectancy from decreasing cardiovascular disease and cancer mortality – an analysis of 28 european countries 1995-2019.

EUROPEAN JOURNAL OF EPIDEMIOLOGY 2023 Nov;37(11):1141-1152

IF: 13,6